Nitin Parekh work email
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
- Valid
Nitin Parekh personal email
- Valid
- Valid
- Valid
Nitin Parekh phone numbers
A global business executive, entrepreneur and industry leader with international multifunctional team building experience who possesses the ability to successfully implement strategic and tactical leadership for internal growth and partnering. Experienced in small and large molecules drug developments for startups, biotech and larger pharma companies leading to commercialization and growth of contract business. Skilled in managing P&L, leading and supervising teams, raise capital and understanding capital markets for technology and financial investment (VC, Private Equity and Independent Investors and Partners). Well experienced in executing corporate strategy for M&A activity portfolio. A proven leader in identifying partnering and acquisition of business, projects and targets in the areas of drug development and small molecule CDMO business development. Lead two large pharma manufacturing and CDMO acquisitions.
Espicor International
-
President And CeoEspicor InternationalNew York, Ny, Us
-
President & CeoEspicor International Apr 2023 - PresentStrategic advisors to pharmaceutical, biotech & chemical industries. Provide mentoring, entrepreneur investing, board membership, drug development strategy, CDMO business growth, CMC and sourcing support. Corporate business strategies, private equity and M&A deals, alliance, partnership management and technology development. Evaluating commercial valuation of the enterprise.
-
Strategy Advisor, Team Member, Scientific And Business Advisory BoardsTen30 Biosciences (2024-Present),, Previously Anven Biosciences (2014-April 2024) Apr 2024 - PresentTen30 Bio leverages a comprehensive drug discovery platform to create oral therapeutics with specificity of peptides and benefits of small molecules. Our targeted protein degradation technology generates novel compounds to potentially treat Cancer, Neurological, Hematology and Autoimmune diseases.Anven Bioscience: Alzheimer, Parkinson, Cancer therapeutics development. Develop bi-functional orally administered molecules and effective therapeutics for targeted protein degradation.
-
Advisory Board - Pre College Programs - Stem /Exec Committee Member-Ip & Enterprise & LicensingNj Institute Of Technology Jan 2016 - PresentPromote and support programs in science, technology, engineering and mathematics (STEM) for pre-college education - Jan 2016-Present/ Portfolio review, licensing and valuation, review inventions for targeted companies for licensing deals and commercialization -Jan 2016-Feb 2024.
-
Management And Advisory Board- Present, Part-Time & Chief Business Officer-2004 - 1 YearVybion, Inc. 1998 - PresentDevelopment of Drug for Huntington’s disease. Started as CDMO for Recombinant Protein Drug manufacturing and MAB catalogue business.
-
Vp/Executive Director - Business Strategy, M&A And Business Development-CdmoSk Pharmteco Apr 2005 - Mar 2023Rancho Cordova , California, UsSignificantly contributed in the growth of small molecule API and CDMO business from a revenue under $50 MM to over $700 million revenue. Actively led the team for two large acquisitions that put the company on the world map. Supported several biotech and large pharma companies in their drug development programs for CDMO and alliance management. -
Advisory Board MemberSouth Carolina Biotech Program (Sc Bio) 2003 - 2010Cultivate life science companies providing assistance to start-up companies from universities in SC. Review viability of the technology and business plans, evaluate financials, established funding criteria, and support partner selection.
-
Vp North America/Vp Business & Technology DevelopmentDsm Pharma Chemicals/Dsm Pharma Products Apr 1991 - Apr 2004Developed extensive market contacts. Participated significantly in the growth of CDMO business. Concluded API manufacturing deals with numerous companies such as Genzyme/Sanofi (anti-cholesterol drug), Merck (antibiotic), and BMS. He was a team member for the acquisition of Catalytica Pharma for DSM.
-
Business Group Leader/Sr. ScientistThe Nutrasweet Co/Monsanto 1990 - 1991Part of the technology group to support business.
-
Business & Technology Group LeaderThe Upjohn Co/ Pfizer 1985 - 1990Supported business with technology and product interaction.
-
Visiting Faculty/Sterling Drugs Staff ResearcherMassachusetts Institute Of Technology 1986 - 1988Cambridge, Ma, UsVisiting faculty/staff at MIT, conducted research and provided guidance to Ph.D. students-1985-1987-Part time Staff Researcher-Sponsored by Sterling Drugs- Novel use of Enzyme Technology to manufacture Chiral Drugs -1984-1985 Full time
Nitin Parekh Skills
Nitin Parekh Education Details
-
Massachusetts Institute Of Technology -
Boston CollegeOrganic Chemistry
Frequently Asked Questions about Nitin Parekh
What company does Nitin Parekh work for?
Nitin Parekh works for Espicor International
What is Nitin Parekh's role at the current company?
Nitin Parekh's current role is President and CEO.
What is Nitin Parekh's email address?
Nitin Parekh's email address is n.****@****jit.edu
What is Nitin Parekh's direct phone number?
Nitin Parekh's direct phone number is +124064*****
What schools did Nitin Parekh attend?
Nitin Parekh attended Massachusetts Institute Of Technology, Boston College.
What skills is Nitin Parekh known for?
Nitin Parekh has skills like Bpo, Technology Transfer, Pharmaceutical Industry, Drug Development, Chemistry, Lifesciences, Gmp, Strategy, Biotechnology, Commercialization, Drug Discovery, Life Sciences.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial